ENvue Medical (FEED) FCF Margin (2014 - 2026)

ENvue Medical (FEED) has 13 years of FCF Margin data on file, last reported at 662.94% in Q1 2026.

• On a quarterly basis, FCF Margin fell 53143.0% year-over-year to 662.94% in Q1 2026; TTM through Mar 2026 was 569.14%, a 44566.0% decrease from a year earlier, with the FY2025 full-year figure at 369.45%, down 27097.0% from the prior year.
• FCF Margin for Q1 2026 stood at 662.94%, up from 865.06% in the prior quarter.
• Over the last five years, FCF Margin for FEED reached as high as 1303.92% in Q4 2022 and fell as low as 2026.8% in Q3 2022.
• Historically, FCF Margin has averaged 342.45% across 5 years, with a median of 276.73% in 2025.
• Across the five-year window, FCF Margin slumped 189955 bps in 2022 and soared 187790 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 1303.92% in 2022, then sank by 103 bps to 41.72% in 2023, then slumped by 196 bps to 123.42% in 2024, then plunged by 601 bps to 865.06% in 2025, then increased by 23 bps to 662.94% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 662.94% in Q1 2026, 865.06% in Q4 2025, and 276.73% in Q3 2025.